Sinovac Biotech Ltd.

$6.47 0%
2026-04-21 09:40:01
NMS: SVA

Explore Sinovac Biotech Ltd. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap
$639.9 M
Current Price
$6.47
52W High / Low
$6.47 / $6.47
Stock P/E
Book Value
$7.52
Dividend Yield
ROCE
-4.19%
ROE
-1.13%
Face Value
EPS
$0.97
Exp Qtr EPS
Sector
Industry
Employees
Beta
Debt / Equity
0.03
Current Ratio
10.31
Quick Ratio
10.18
Forward P/E
-53.92
Price / Sales
Enterprise Value
EV / EBITDA
EV / Revenue
Rating
Buy
Target Price
$3.52
EPS Forecast (FY)

Pros

  • Balance sheet leverage appears manageable.
  • Short-term liquidity looks comfortable.
  • Valuation is not stretched on P/E basis.

Cons

  • Return on equity is on the weaker side.
  • Capital efficiency is modest.
  • Operating margin is thin.

Sift Stocks

S.No. Name Price P.E. Market Cap Div Yld % ROCE ROE 52Week High/ Low Book Value
1. Bank of Montreal $151.36 17.21 $107.34 B 3.21% 10.47% $210.03 / $126.91 $86.08
2. RTX Corporation $181.36 33.94 $244.44 B 1.39% 8.28% 10.95% $214.5 / $112.63 $48.61
3. Costco Wholesale Corporation $1,004.62 52.22 $445.77 B 0.59% 25.96% 29.65% $1,067.08 / $844.06 $37.28
4. Stryker Corporation $334.05 39.78 $127.84 B 1.04% 12.63% 15.08% $404.87 / $319.32 $58.61
5. Netflix, Inc. $93.45 30.22 $394.45 B 29.87% 42.76% $134.12 / $75.01 $6.3
6. Equinix, Inc. $1,102.62 80.07 $108.51 B 1.87% 5.42% 9.72% $1,104.29 / $710.52 $144.12
7. Tesla, Inc. $391.65 364.28 $1,226.85 B 4.57% 4.93% $498.83 / $222.79 $21.9

Quarterly Results

Figures shown in M / B

Sales
Operating Profit
Net Profit
EPS in Rs

Profit & Loss

Figures shown in M / B

202320222021
Sales448.27 M1.49 B19.37 B
Operating Profit-524.3 M-460.85 M17.55 B
Net Profit-99.92 M113.87 M8.47 B
EPS in Rs-1.011.1585.28

Balance Sheet

Figures shown in M / B

202320222021
Total Assets13.66 B14.11 B16.75 B
Total Liabilities1.64 B1.4 B2.87 B
Equity8.71 B8.92 B9.33 B
Current Assets11.83 B12.13 B14.92 B
Current Liabilities1.15 B1.09 B2.41 B

Cash Flow

Last available yearly cash flow history

202320222021
Operating CF104 M-770.75 M15.35 B
Investing CF-2.92 B-5.76 B-3.02 B
Financing CF-76.06 M-241.4 M-1.9 B
Free CF-41.69 M-1.17 B14.63 B
Capex-145.69 M-403.37 M-719.98 M

5Y Margin & Growth History

Last 5 year derived history from yfinance annual statements

202320222021
Revenue Growth %-69.97%-92.3%
Earnings Growth %-187.75%-98.66%
Profit Margin %-22.29%7.63%43.7%
Operating Margin %-116.96%-30.87%90.6%
Gross Margin %59.51%54.15%94.47%
EBITDA Margin %-1.34%12.27%91.11%

Dividend & Split History

Latest dividend and stock split events stored from yfinance

Dividend History

Ex DateDividend
2025-07-08$55

Stock Splits

No stock split history available.

Shareholding Pattern

Shares and value shown in M / B

Shareholding data not available.